IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...

Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major ...

By all means, if you’ve been told that exercise is non-negotiable for diabetes management, you’ve heard right. But what they ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Among adult patients with type 2 diabetes, CGM prescriptions less likely for those with non-English language preference.

The University of Cincinnati's Robert Cohen, MD, commented to MedCentral on two new studies presented at the American ...

The Grammy-nominated musicians discuss what's helping them manage, and why they’re using their platform to reach the Black ...